Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 1–50 of 94 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04913337	Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies	unknown	Phase 1 / Phase 2	179	NGM Biopharmaceuticals, IncINDUSTRY	3	Oct 2, 2024	clinicaltrials
NCT05867303	A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors	unknown	Phase 1	48	RemeGen Co., Ltd.INDUSTRY	2	Aug 16, 2024	clinicaltrials